Skip to content
healthcare.dev

SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension

RxNorm concept 2691196, clinical drug (scd). Prescribable name: SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA).

RxCUI
2691196
Term type
Clinical drug (SCD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691196 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA)

Related concepts

Linked data

NDCs

  • 59267442601
  • 59267442602

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2691196 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691196 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 2691196. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.